FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2480434080> ?p ?o ?g. }

• W2480434080 endingPage "902" @default.
• W2480434080 startingPage "893" @default.
• W2480434080 abstract "Previous studies have revealed the association of multidrug resistance with histone deacetylases inhibitors treatment in cancer cells. But little data were available for the correlation of histone deacetylases and drug-resistant-related proteins in breast cancer tissue. This study aimed to exploring the association of histone deacetylases expression with clinicopathological features, drug-resistant-related proteins, prognosis and therapeutic responses in breast cancer patients.We performed immunohistochemistry to study the expression of HDAC1 and HDAC2 in 226 breast cancer and 34 breast fibroadenoma patients, and the expression of breast cancer resistance protein, P-glycoprotein, lung resistance protein and multidrug resistance protein in 226 breast cancer.In breast cancer, HDAC2 expression was significantly increased than in fibroadenoma (P = 0.015), and correlated with lymph node metastasis (P = 0.002), advanced clinical stages (P = 0.016) and high histological grade (P = 0.001). Significant positive correlations were found between HDAC2 and Ki67, HDAC1 and multidrug resistance protein, HDAC2 and breast cancer resistance protein, HDAC2 and multidrug resistance protein. HDAC2 positive expression was associated with shorter overall survival (P = 0.035) of breast cancer patients. In addition, HDAC2-positive expression was significantly associated with shorter overall survival in multidrug resistance protein-positive patients (P = 0.034), but not in multidrug resistance protein-negative patients (P = 0.530). HDAC2-positive expression was associated with shorter survival in patients who received chemotherapy containing anthracyclines (overall survival, P = 0.041; disease-free survival, P = 0.084), but not in patients who received chemotherapy without anthracyclines (overall survival, P = 0.679; disease-free survival, P = 0.708).HDAC2 overexpression correlated with the metastasis, progression and the increased Ki67, multidrug resistance protein expression in breast cancer, and HDAC2 could be a prognostic factor of breast cancer patients, especially the patients who received anthracyclines therapy." @default.
• W2480434080 created "2016-08-23" @default.
• W2480434080 creator A5005469909 @default.
• W2480434080 creator A5031345742 @default.
• W2480434080 creator A5035209592 @default.
• W2480434080 creator A5041804403 @default.
• W2480434080 creator A5052556650 @default.
• W2480434080 creator A5062251557 @default.
• W2480434080 creator A5064055416 @default.
• W2480434080 creator A5072863292 @default.
• W2480434080 creator A5073474899 @default.
• W2480434080 date "2016-10-01" @default.
• W2480434080 modified "2023-10-06" @default.
• W2480434080 title "HDAC2 overexpression is a poor prognostic factor of breast cancer patients with increased multidrug resistance-associated protein expression who received anthracyclines therapy" @default.
• W2480434080 cites W1658998365 @default.
• W2480434080 cites W1843609228 @default.
• W2480434080 cites W1968931590 @default.
• W2480434080 cites W1970073792 @default.
• W2480434080 cites W1971947676 @default.
• W2480434080 cites W1972149587 @default.
• W2480434080 cites W1976153898 @default.
• W2480434080 cites W1978044485 @default.
• W2480434080 cites W1983051513 @default.
• W2480434080 cites W1983094204 @default.
• W2480434080 cites W1985857257 @default.
• W2480434080 cites W1986757639 @default.
• W2480434080 cites W2015047229 @default.
• W2480434080 cites W2019967976 @default.
• W2480434080 cites W2048379863 @default.
• W2480434080 cites W2049661083 @default.
• W2480434080 cites W2075625882 @default.
• W2480434080 cites W2077834781 @default.
• W2480434080 cites W2089077371 @default.
• W2480434080 cites W2110362707 @default.
• W2480434080 cites W2118827241 @default.
• W2480434080 cites W2119142674 @default.
• W2480434080 cites W2123391508 @default.
• W2480434080 cites W2123649043 @default.
• W2480434080 cites W2124086839 @default.
• W2480434080 cites W2129857647 @default.
• W2480434080 cites W2133408654 @default.
• W2480434080 cites W2149099455 @default.
• W2480434080 cites W2150455384 @default.
• W2480434080 cites W2152966058 @default.
• W2480434080 cites W2153673379 @default.
• W2480434080 cites W2166424822 @default.
• W2480434080 cites W2167992541 @default.
• W2480434080 cites W2170679339 @default.
• W2480434080 doi "https://doi.org/10.1093/jjco/hyw096" @default.
• W2480434080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27432453" @default.
• W2480434080 hasPublicationYear "2016" @default.
• W2480434080 type Work @default.
• W2480434080 sameAs 2480434080 @default.
• W2480434080 citedByCount "33" @default.
• W2480434080 countsByYear W24804340802016 @default.
• W2480434080 countsByYear W24804340802017 @default.
• W2480434080 countsByYear W24804340802018 @default.
• W2480434080 countsByYear W24804340802019 @default.
• W2480434080 countsByYear W24804340802020 @default.
• W2480434080 countsByYear W24804340802021 @default.
• W2480434080 countsByYear W24804340802022 @default.
• W2480434080 countsByYear W24804340802023 @default.
• W2480434080 crossrefType "journal-article" @default.
• W2480434080 hasAuthorship W2480434080A5005469909 @default.
• W2480434080 hasAuthorship W2480434080A5031345742 @default.
• W2480434080 hasAuthorship W2480434080A5035209592 @default.
• W2480434080 hasAuthorship W2480434080A5041804403 @default.
• W2480434080 hasAuthorship W2480434080A5052556650 @default.
• W2480434080 hasAuthorship W2480434080A5062251557 @default.
• W2480434080 hasAuthorship W2480434080A5064055416 @default.
• W2480434080 hasAuthorship W2480434080A5072863292 @default.
• W2480434080 hasAuthorship W2480434080A5073474899 @default.
• W2480434080 hasBestOaLocation W24804340801 @default.
• W2480434080 hasConcept C104317684 @default.
• W2480434080 hasConcept C114851261 @default.
• W2480434080 hasConcept C121608353 @default.
• W2480434080 hasConcept C126322002 @default.
• W2480434080 hasConcept C133936738 @default.
• W2480434080 hasConcept C143998085 @default.
• W2480434080 hasConcept C2776694085 @default.
• W2480434080 hasConcept C2778305200 @default.
• W2480434080 hasConcept C502942594 @default.
• W2480434080 hasConcept C530470458 @default.
• W2480434080 hasConcept C55493867 @default.
• W2480434080 hasConcept C64927066 @default.
• W2480434080 hasConcept C71723506 @default.
• W2480434080 hasConcept C71924100 @default.
• W2480434080 hasConcept C86803240 @default.
• W2480434080 hasConcept C89423630 @default.
• W2480434080 hasConceptScore W2480434080C104317684 @default.
• W2480434080 hasConceptScore W2480434080C114851261 @default.
• W2480434080 hasConceptScore W2480434080C121608353 @default.
• W2480434080 hasConceptScore W2480434080C126322002 @default.
• W2480434080 hasConceptScore W2480434080C133936738 @default.
• W2480434080 hasConceptScore W2480434080C143998085 @default.
• W2480434080 hasConceptScore W2480434080C2776694085 @default.
• W2480434080 hasConceptScore W2480434080C2778305200 @default.
• W2480434080 hasConceptScore W2480434080C502942594 @default.

• next